SC-52012

CAS No. 145643-15-8

SC-52012( —— )

Catalog No. M33119 CAS No. 145643-15-8

SC-52012 is a novel and potent fibrinogen receptor antagonist, an RGD mimetic, which inhibits platelet aggregation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1064 Get Quote
5MG 1710 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SC-52012
  • Note
    Research use only, not for human use.
  • Brief Description
    SC-52012 is a novel and potent fibrinogen receptor antagonist, an RGD mimetic, which inhibits platelet aggregation.
  • Description
    HY-19163 is an orally active fibrinogen receptor antagonist, with antiplatelet activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    145643-15-8
  • Formula Weight
    482.53
  • Molecular Formula
    C25H30N4O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@H](C(N[C@@H](CC1=CC=CC=C1)C(O)=O)=O)(NC(CCCCC2=CC=C(C(=N)N)C=C2)=O)CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zablocki JA, et al. A novel series of orally active antiplatelet agents. Bioorg Med Chem. 1995 May;3(5):539-51.?
molnova catalog
related products
  • Hosenkoside C

    Hosenkoside C is a baccharane glycoside isolated from the seeds of Impatiens balsamina.

  • Methomyl Oxime

    Methomyl is the active ingredient in commercial fly bait granules which are mixed with a cola drink to kill bothersome raccoon, skunk and opossum.

  • steviolbioside

    Steviolbioside is a natural sweetener it presents notable inhibition on human hepatocarcinoma cell Hep3B human breast cancer cell MDA-MB-231 and human pancreatic cancer cell BxPC-3 thus steviolbioside could be a potential remedy for human breast cancer.